Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

Has anyone tried Alferon LDO® (Low Dose Oral)?

Discussion in 'Antivirals, Antibiotics and Immune Modulators' started by Carrigon, May 15, 2012.

  1. Carrigon

    Carrigon Senior Member

    PA, USA
    Apparently, Alferon LDO® (Low Dose Oral) is the pill form of Ampligen that Hemispherx is working on. I'm extremely interested in it, but the FDA will no doubt never approve it.

See more popular forum discussions.

Share This Page